姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Wang,Xue-Hong | Chairman | 3.86% | |
Chen,Wen-Qi | Director | 2.68% | |
Zhuo,Huo-Tu | Director | 0.01% | |
David Bruce Yoffie | Director | 0.00% | |
Lin,Zhen-Guo | Independent Director | 0.00% | |
Vincent Thai | Independent Director | 0.00% | |
Michael C. Lu | Independent Director | 0.00% | |
Xie,Hong-Zhong | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 708,312 | 3,080,984 | 4,417,932 |
Operating cost | 441,906 | 1,827,140 | 2,594,222 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 266,406 | 1,253,844 | 1,823,710 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 266,406 | 1,253,844 | 1,823,710 |
Operating expenses | 1,410,545 | 5,893,181 | 6,118,391 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -1,144,139 | -4,639,337 | -4,294,681 |
Non-operating income and expenses | 7,313,288 | 1,222,552 | 896,003 |
Net profit (loss) before tax | 6,169,149 | -3,416,785 | -3,398,678 |
Income tax expense (benefits) | 2,114,620 | 1,503 | -2,921 |
Net profit (loss) of ongoing business for the current period | 4,054,529 | -3,418,288 | -3,395,757 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 4,054,529 | -3,418,288 | -3,395,757 |
Other comprehensive profit (loss), net | 384,040 | 2,019,540 | 506,133 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 4,438,569 | -1,398,748 | -2,889,624 |
Net profit (loss) attributable to owners of parent company | 4,054,529 | -3,418,288 | -3,395,757 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | 4,438,569 | -1,398,748 | -2,889,624 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 4 | -4 | -4 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | -1,574,973 | -2,537,933 | -4,049,032 |
Net cash inflows (outflows) from investing activities | 14,015,175 | 752,571 | -4,894,019 |
Net cash inflow (outflow) from financing activities | 351,918 | 2,525,201 | 3,286,374 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 559,610 | 1,060,007 | 348,910 |
Increase (decrease) in cash and cash equivalents in the current period | 13,351,730 | 1,799,846 | -5,307,767 |
Beginning balance of cash and cash equivalents | 14,239,209 | 12,439,363 | 17,747,130 |
Ending balance of cash and cash equivalents | 27,590,939 | 14,239,209 | 12,439,363 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 33,173,377 | 26,996,749 | 26,900,804 |
Non-current asset | 17,833,397 | 19,234,721 | 18,682,504 |
Total asset | 51,006,774 | 46,231,470 | 45,583,308 |
Current liability | 12,948,876 | 12,739,356 | 13,501,340 |
Non-current liability | 12,132,366 | 12,063,845 | 9,276,840 |
Total liability | 25,081,242 | 24,803,201 | 22,778,180 |
share capital | 8,351,955 | 8,335,340 | 8,320,380 |
Equity - secruity token | - | - | - |
capital reserve | 16,319,644 | 16,277,565 | 16,270,636 |
retained earning | 3,165,608 | -794,015 | 1,571,162 |
Other equity | -1,911,675 | -2,390,621 | -3,357,050 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 25,925,532 | 21,428,269 | 22,805,128 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 25,925,532 | 21,428,269 | 22,805,128 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 31 | 25 | 27 |
標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
---|---|---|---|---|
醫院消防安全虛擬實境訓練教案拍攝及製作1式 | 國立臺灣大學醫學院附設醫院 | 114/05/22 | 334000.0 | 是 |
教育元宇宙平台服務之使用費勞務採購案 | 國立清華大學 | 114/03/31 | 1720000.0 | 是 |
洗腎機等10項設備採購案 | 臺中榮民總醫院 | 114/02/26 | 210000.0 | 是 |
多元教材線上學習網維護含虛擬實境擴增資訊服務2年 | 臺北榮民總醫院 | 113/12/11 | 374000.0 | 是 |
VR 3D Organon永久授權單機版、VIVE XR Elite 解剖虛擬實境頭盔收納套組 | 國立陽明交通大學 | 113/10/23 | 900000.0 | 是 |
VR頭戴式顯示器含自定位追蹤模組 | 國立臺北護理健康大學 | 113/08/29 | 345000.0 | 是 |
圍術期危機處理VR模擬教學教材客製化軟體開發採購案 | 臺中榮民總醫院 | 113/07/29 | 910000.0 | 是 |
多元教材推動平台資訊服務 | 臺北榮民總醫院 | 113/07/11 | 645000.0 | 是 |
Virti互動式360影片教案設計製作工作坊 | 國立臺灣大學 | 113/05/21 | 300000.0 | 是 |
XR-CPR軟體授權採購案 | 臺中榮民總醫院 | 113/05/16 | 745000.0 | 是 |
113年度智慧XR警勤訓練建置案 | 內政部警政署 | 113/04/30 | 否 | |
臺大醫學院VR頭戴式顯示器組 | 國立臺灣大學 | 113/04/02 | 280000.0 | 是 |
「5G移動專網設備租用」採購案 | 南臺學校財團法人南臺科技大學 | 113/02/06 | 5000000.0 | 是 |
「教育元宇宙平台服務之使用費」勞務採購案 | 國立屏東大學 | 113/01/11 | 2400000.0 | 是 |
多元教材推動平台 | 臺北榮民總醫院 | 112/12/26 | 否 | |
多元教材線上學習網維護含虛擬實境擴增資訊服務 | 臺北榮民總醫院 | 112/12/07 | 189000.0 | 是 |
虛擬實境教案建置編輯平台及相關硬體設備 | 國立臺灣大學 | 112/10/26 | 220000.0 | 是 |
VR教學平台互動式360影片教案研改 | 國防醫學院 | 112/10/18 | 292000.0 | 是 |
護理學系籌備處採購解剖生理學虛擬實境(VR)教材 | 國立暨南國際大學 | 112/07/14 | 510000.0 | 是 |
「教育元宇宙平台服務之使用」勞務採購案 | 國立屏東大學 | 112/04/19 | 8400000.0 | 是 |
「新竹市文化局數位雙生科普實驗室內容設計委託專業服務案」第二次契約變更 | 新竹市文化局 | 112/01/31 | 230400.0 | 是 |
創新教學軟體與培訓課程採購 | 國立臺灣大學 | 111/11/29 | 930000.0 | 是 |
「新竹市文化局數位雙生科普實驗室內容設計委託專業服務案」第一次契約變更 | 新竹市文化局 | 111/11/09 | 2557700.0 | 是 |
人體解剖訓練器套組 | 國立臺灣大學 | 111/11/01 | 530000.0 | 是 |
3D人體解剖教學軟體及虛擬實境設備 | 國立臺灣師範大學 | 111/10/27 | 312000.0 | 是 |
111年度長照大樓護理之家虛擬實境(VR)設備採購案 | 臺中榮民總醫院嘉義分院 | 111/10/25 | 107000.0 | 是 |
未來教室VR設備採購 | 國立臺灣大學 | 111/10/12 | 820000.0 | 是 |
高雄百點集章行動NFT製作勞務採購案 | 高雄市政府文化局 | 111/08/05 | 760000.0 | 是 |
新竹市文化局數位雙生科普實驗室內容設計委託專業服務案 | 新竹市文化局 | 111/07/28 | 23420000.0 | 是 |
虛擬實境電子書 | 中臺科技大學 | 111/07/05 | 125000.0 | 是 |
虛擬實境(VR)教學及教案製作軟體及硬體設備乙批整合採購 | 國立嘉義大學 | 111/06/23 | 340000.0 | 是 |
3D Organon 人體解剖教學系統 | 大葉大學 | 111/06/01 | 2460000.0 | 是 |
虛擬實境牙醫學訓練系統 | 中國醫藥大學 | 111/06/01 | 否 | |
教案設計製作工作坊18小時及6個一年期Virti帳號 | 國立臺灣大學醫學院附設醫院 | 110/12/13 | 268000.0 | 是 |
110年度虛擬實境森林開發工具曁生理回饋分析儀器組採購案 | 國立臺灣大學生物資源暨農學院實驗林管理處 | 110/11/04 | 1346000.0 | 是 |
互動式360影片教案平台 | 國防醫學院 | 110/09/16 | 675000.0 | 是 |
內政部警政署110年度智慧XR警勤訓練建置案 | 內政部警政署 | 110/06/01 | 否 | |
HTC手機乙批採購案 | 外交部 | 101/04/05 | 152320.0 | 是 |
太誼專案手機禮品採購案 | 外交部 | 099/03/05 | 995000.0 | 是 |
日期 | 違反法規法條 | 罰鍰金額 |
---|---|---|
2021/12/17 | Paragraph 5, Article 30 of the Labor Standards Act | 120,000 |
2021/04/16 | Paragraph 6, Article 30 of the Labor Standards Act | 240,000 |
2021/04/16 | Article 24 of the Labor Standards Act | 48,000 |
2020/12/03 | Paragraph 1, Article 36 of the Labor Standards Act | 50,000 |
2019/06/18 | Paragraph 6, Article 30 of the Labor Standards Act | |
2019/03/08 | Paragraph 1, Article 24 of the Labor Standards Act | |
2018/01/08 | Paragraph 2, Article 22 of the Labor Standards Act | |
2017/10/11 | Paragraph 1, Article 6 of the Occupational Safety and Health Act | |
2017/04/20 | Article 39 of the Labor Standards Act | |
2016/12/10 | Article 37 of the Labor Standards Act | |
2016/11/06 | Article 24 of the Labor Standards Act | |
2016/11/06 | Paragraph 2, Article 32 of the Labor Standards Act | |
2016/05/06 | Article 36 of the Labor Standards Act | |
2016/05/06 | Paragraph 2, Article 32 of the Labor Standards Act | |
2016/03/06 | Paragraph 5, Article 30 of the Labor Standards Act | |
2016/01/10 | Paragraph 2, Article 32 of the Labor Standards Act |